Select a medication above to begin.
Wixela Inhub
fluticasone propionate/ salmeterol inhaled
Adult Dosing .
Dosage forms: DPI: 100 mcg/50 mcg per actuation, 250 mcg/50 mcg per actuation, 500 mcg/50 mcg per actuation
asthma, maintenance tx
- [1 puff (100 mcg/50 mcg, 250 mcg/50 mcg, or 500 mcg/50 mcg per actuation) inhaled q12h]
- Start: varies by dz severity and current asthma tx, may incr. dose after 2wk; Max: 1000 mcg/100 mcg/day; Info: taper to lowest effective dose; search 'asthma' for epocrates Asthma Long-Term Mgmt NIH/NHLBI decision tools
COPD, maintenance tx
- [1 puff (250 mcg/50 mcg per actuation) inhaled q12h]
- Info: search 'gold' for epocrates COPD GOLD decision tools
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- hepatic impairment: not defined, caution advised
Peds Dosing .
- Dosage forms: DPI: 100 mcg/50 mcg per actuation, 250 mcg/50 mcg per actuation, 500 mcg/50 mcg per actuation
asthma, maintenance tx
- [4-11 yo]
- Dose: 1 puff (100 mcg/50 mcg per actuation) inhaled q12h; Info: taper to lowest effective dose; search 'asthma' for epocrates Asthma Long-Term Mgmt NIH/NHLBI decision tools
- [12 yo and older]
- Dose: 1 puff (100 mcg/50 mcg, 250 mcg/50 mcg, or 500 mcg/50 mcg per actuation) inhaled q12h; Start: varies by dz severity and current asthma tx, may incr. dose after 2wk; Max: 1000 mcg/100 mcg/day; Info: taper to lowest effective dose; search 'asthma' for epocrates Asthma Long-Term Mgmt NIH/NHLBI decision tools
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- hepatic impairment: not defined, caution advised
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
- hypersensitivity to milk protein, severe (DPI form)
- status asthmaticus
- asthma, acute
- bronchospasm, acute
- COPD, acute deteriorating
- abrupt withdrawal
- caution: hypersensitivity to corticosteroids
- caution: peds pts
- caution: adolescent pts
- caution: MAO inhibitor use w/in 14 days
- caution: TCA use w/in 14 days
- caution: electrolyte abnormalities
- caution: long QT syndrome, congenital
- caution: QT prolongation
- caution: QT prolongation family hx
- caution: torsades de pointes hx
- caution: arrhythmia
- caution: bradycardia
- caution: MI, recent
- caution: CHF
- caution: cardiovascular dz
- caution: pts unusually responsive to sympathomimetic amines
- caution: diabetes mellitus
- caution: ketoacidosis
- caution: seizure disorder
- caution: hyperthyroidism
- caution: labor and delivery
- caution: hepatic impairment
- caution: long-term systemic corticosteroid use, recent
- caution: immunosuppressed pts
- caution: infection, active
- caution: TB infection, active
- caution: TB infection, latent
- caution: measles exposure
- caution: varicella exposure
- caution: ocular HSV
- caution: glaucoma
- caution: glaucoma risk
- caution: cataract
- caution: osteoporosis
- caution: osteoporosis risk
Drug Interactions .
Overview
fluticasone propionate
corticosteroid
- CYP3A4 substrate
- immunosuppressive effects
- interferes w/ ACTH analog test
salmeterol inhaled
beta-2 agonist
- CYP3A4 substrate
- hypertensive effects
- hypokalemia
- prolongs QT interval (conditional)
- tachycardia
Contraindicated
- desmopressin
- pimozide
- thioridazine
Avoid/Use Alternative
- acebutolol
- adagrasib
- albuterol
- arformoterol inhaled
- arsenic trioxide
- atazanavir
- atenolol
- bedaquiline
- betaxolol
- bisoprolol
- carvedilol
- ceritinib
- chloramphenicol
- cisapride
- cladribine oral
- clarithromycin
- cobicistat
- cocaine
- conivaptan
- crizotinib
- darunavir
- desipramine
- domperidone
- dronabinol
- ephedra
- epinephrine inhaled
- esmolol
- fexinidazole
- formoterol inhaled
- fosamprenavir
- furosemide
- hydroxychloroquine
- idelalisib
- itraconazole
- ketoconazole
- labetalol
- landiolol
- lefamulin
- levoketoconazole
- lonafarnib
- lopinavir/ritonavir
- metoprolol
- midodrine
- mifepristone
- mobocertinib
- nadolol
- natalizumab
- nebivolol
- nefazodone
- nelfinavir
- olodaterol inhaled
- phenelzine
- pimecrolimus topical
- pindolol
- posaconazole
- procarbazine
- propranolol
- quizartinib
- ribociclib
- ritonavir
- salmeterol inhaled
- sotalol
- timolol
- tipranavir
- toremifene
- tucatinib
- vandetanib
- vilanterol inhaled
- voriconazole
- ziprasidone
Monitor/Modify Tx
- abiraterone acetate
- acetazolamide
- albuterol inhaled
- aliskiren
- almotriptan
- aloe
- amiloride
- aminophylline
- amiodarone
- amitriptyline
- amlodipine
- amoxapine
- amphetamine
- amphotericin
- anagrelide
- angiotensin II
- apalutamide
- apomorphine
- aprocitentan
- armodafinil
- artemether/lumefantrine
- asciminib
- asenapine
- asparaginase
- atogepant
- atomoxetine
- atropine
- atropine ophthalmic
- axitinib
- azilsartan medoxomil
- azithromycin
- benazepril
- benzphetamine
- benztropine
- betamethasone
- bevacizumab
- bismuth subsalicylate
- brigatinib
- budesonide
- bumetanide
- bupropion
- cabozantinib
- caffeine
- caffeine citrate
- candesartan cilexetil
- cannabis
- captopril
- carboplatin
- carfilzomib
- celecoxib
- cetuximab
- chloroquine
- chlorothiazide
- chlorthalidone
- cisplatin
- citalopram
- clevidipine
- clofazimine
- clomipramine
- clonidine
- copanlisib
- corticotropin
- cortisone
- cosyntropin
- cyclosporine
- danazol
- darbepoetin alfa
- decitabine
- deflazacort
- degarelix
- desflurane
- desvenlafaxine
- dexamethasone
- dexmedetomidine
- dexmedetomidine injection
- dexmethylphenidate
- dextroamphetamine
- dichlorphenamide
- diclofenac
- diclofenac topical
- dicyclomine
- diethylpropion
- diflunisal
- digoxin
- dihydroergotamine
- diltiazem
- dinutuximab
- disopyramide
- dobutamine
- dofetilide
- donepezil
- dopamine
- doxapram
- doxazosin
- doxepin
- dronedarone
- droperidol
- droxidopa
- eletriptan
- emapalumab
- enalapril
- enalaprilat
- encorafenib
- enzalutamide
- ephedrine injection
- ephedrine oral
- epinephrine
- epirubicin
- eplerenone
- epoetin alfa
- eptinezumab
- erenumab
- ergotamine
- eribulin
- erythromycin
- esketamine
- estetrol (contraceptive)
- estradiol (contraceptive)
- ethacrynic acid
- ethinyl estradiol (contraceptive)
- etodolac
- etrasimod
- everolimus
- felodipine
- fenfluramine
- fenoldopam
- fenoprofen
- fingolimod
- flecainide
- fludrocortisone
- fluorouracil
- flurbiprofen
- foscarnet
- fosinopril
- fostamatinib
- fremanezumab
- frovatriptan
- fruquintinib
- galcanezumab
- gilteritinib
- glasdegib
- glycopyrrolate
- goserelin
- guanfacine
- haloperidol
- histrelin
- hoodia
- hydralazine
- hydrochlorothiazide
- hydrocortisone
- hydroxyzine
- hyoscyamine
- ibrutinib
- ibuprofen
- ibutilide
- imipramine
- indapamide
- indomethacin
- inotuzumab ozogamicin
- insulin
- irbesartan
- isocarboxazid
- isoflurane
- isoproterenol
- isradipine
- ivosidenib
- ketamine
- ketoprofen
- ketorolac
- lanreotide
- leflunomide
- lenalidomide
- lenvatinib
- leuprolide
- levalbuterol inhaled
- levofloxacin
- levomilnacipran
- levothyroxine
- licorice
- lifileucel
- linezolid
- liothyronine
- liraglutide
- lisdexamfetamine
- lisinopril
- lofexidine
- lorlatinib
- losartan
- lumacaftor/ivacaftor
- luspatercept
- macimorelin
- magnesium citrate
- magnesium salicylate
- mannitol
- meclofenamate
- mefenamic acid
- meloxicam
- methacholine inhaled
- methadone
- methamphetamine
- methazolamide
- methoxy polyethylene glycol-epoetin beta
- methscopolamine
- methyldopa
- methylergonovine
- methylphenidate
- methylprednisolone
- methyltestosterone
- metoclopramide
- metolazone
- metyrapone
- milnacipran
- minoxidil
- mirabegron
- modafinil
- moexipril
- motixafortide
- moxifloxacin
- nabumetone
- naproxen
- naratriptan
- naxitamab
- necitumumab
- nicardipine
- nifedipine
- nilotinib
- nimodipine
- niraparib
- nisoldipine
- norepinephrine
- nortriptyline
- oliceridine
- olmesartan medoxomil
- ondansetron
- orphenadrine
- osilodrostat
- osimertinib
- oxaprozin
- oxymetazoline nasal
- oxytocin
- ozanimod
- pacritinib
- paliperidone
- palonosetron
- pamidronate
- panitumumab
- panobinostat
- pasireotide
- pazopanib
- pentamidine
- perindopril
- pexidartinib
- phendimetrazine
- phenoxybenzamine
- phentermine
- phentolamine
- phenylephrine
- phenylephrine injection
- phenylephrine nasal
- phenylephrine ophthalmic
- phenylephrine rectal
- piroxicam
- polyethylene glycol
- polyethylene glycol/electrolytes
- ponatinib
- ponesimod
- pralsetinib
- prazosin
- prednisolone
- prednisone
- procainamide
- propafenone
- protriptyline
- pseudoephedrine
- quetiapine
- quinapril
- quinidine (antiarrhythmic)
- quinidine (CYP2D6 inhibitor)
- quinine
- ramipril
- ramucirumab
- rasagiline
- regorafenib
- revumenib
- rimegepant
- ripretinib
- rizatriptan
- romidepsin
- ropinirole
- rotigotine transdermal
- rucaparib
- sacituzumab govitecan
- safinamide
- salsalate
- selegiline
- selegiline transdermal
- selinexor
- selpercatinib
- sevoflurane
- siponimod
- sirolimus albumin-bound
- sodium benzoate
- sodium phenylacetate
- sodium phenylbutyrate
- sodium polystyrene sulfonate
- sodium thiosulfate
- solriamfetol
- sorafenib
- spironolactone
- sulfate bowel prep
- sulindac
- sumatriptan
- sunitinib
- tacrolimus
- tafasitamab
- tagraxofusp
- telavancin
- telmisartan
- temsirolimus
- terazosin
- terbutaline
- teriflunomide
- testosterone
- tetrabenazine
- theophylline
- thyroid
- tivozanib
- tolmetin
- topiramate
- torsemide
- tramadol
- trametinib
- trandolapril
- tranylcypromine
- trastuzumab
- triamcinolone
- triamterene
- triclabendazole
- trifluridine
- trimipramine
- triptorelin
- trospium
- ubrogepant
- vadadustat
- valsartan
- vamorolone
- vasopressin
- vemurafenib
- venlafaxine
- verapamil
- viloxazine
- voclosporin
- yohimbe
- zavegepant
- ziv-aflibercept
- zolmitriptan
- zonisamide
Caution Advised
- abatacept
- abemaciclib
- abrocitinib
- acalabrutinib
- adalimumab
- afamitresgene autoleucel
- aldesleukin
- alemtuzumab
- anakinra
- anifrolumab
- anti-thymocyte globulin
- atidarsagene autotemcel
- avacopan
- axicabtagene ciloleucel
- azacitidine
- azathioprine
- baricitinib
- basiliximab
- beclomethasone inhaled
- beclomethasone nasal
- belatacept
- belimumab
- belinostat
- bendamustine
- bimekizumab
- blinatumomab
- bortezomib
- brentuximab vedotin
- brexucabtagene autoleucel
- brodalumab
- budesonide inhaled
- budesonide nasal
- budesonide rectal
- busulfan
- cabazitaxel
- canakinumab
- carmustine
- certolizumab pegol
- chlorambucil
- ciltacabtagene autoleucel
- cladribine injection
- clobetasol ophthalmic
- clofarabine
- crovalimab
- cyclophosphamide
- cytarabine
- dactinomycin
- danicopan
- daratumumab
- daunorubicin
- delgocitinib topical
- deucravacitinib
- deuruxolitinib
- dexamethasone ophthalmic
- difluprednate ophthalmic
- dimethyl fumarate
- diroximel fumarate
- docetaxel
- doxorubicin
- dupilumab
- duvelisib
- eculizumab
- efgartigimod alfa
- elivaldogene autotemcel
- elotuzumab
- elranatamab
- epcoritamab
- etanercept
- etoposide
- floxuridine
- fludarabine
- flunisolide nasal
- fluocinolone intravitreal
- fluorometholone ophthalmic
- fluticasone furoate
- gemtuzumab ozogamicin
- glofitamab
- golimumab
- guselkumab
- hydrocortisone ophthalmic
- hydroxyurea
- ibritumomab tiuxetan
- idarubicin
- idecabtagene vicleucel
- ifosfamide
- inebilizumab
- infliximab
- iptacopan
- irinotecan
- isatuximab
- ixabepilone
- ixekizumab
- lebrikizumab
- linvoseltamab
- lisocabtagene maraleucel
- lomustine
- loncastuximab tesirine
- loteprednol ophthalmic
- lymphocyte immune globulin, anti-thymocyte globulin
- melphalan
- mercaptopurine
- methotrexate
- mirikizumab
- mitoxantrone
- mogamulizumab
- momelotinib
- mometasone implant
- mometasone inhaled
- mometasone nasal
- monomethyl fumarate
- mosunetuzumab
- mycophenolate mofetil
- mycophenolic acid
- nelarabine
- nipocalimab
- obecabtagene autoleucel
- obinutuzumab
- ocrelizumab
- ofatumumab
- oxaliplatin
- paclitaxel
- pegcetacoplan
- pentostatin
- pirtobrutinib
- polatuzumab vedotin
- pomalidomide
- pozelimab
- prednisolone ophthalmic
- ravulizumab
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- ropeginterferon alfa-2b
- rozanolixizumab
- ruxolitinib
- ruxolitinib topical
- sarilumab
- satralizumab
- secukinumab
- siltuximab
- sirolimus
- spesolimab
- sulfasalazine
- sutimlimab
- talquetamab
- tarlatamab
- teclistamab
- temozolomide
- teplizumab
- thioguanine
- thiotepa
- tildrakizumab
- tisagenlecleucel
- tocilizumab
- tofacitinib
- topotecan
- tralokinumab
- ublituximab
- upadacitinib
- ustekinumab
- vedolizumab
- venetoclax
- vilobelimab
- vinblastine
- vincristine
- vinorelbine
- zanubrutinib
- zilucoplan
Adverse Reactions .
Serious Reactions
- bronchospasm, paradoxical
- asthma exacerbation
- pneumonia (COPD use)
- hypersensitivity rxn
- anaphylaxis
- HTN
- angina
- arrhythmia
- hypokalemia
- hyperglycemia
- Churg-Strauss syndrome
- adrenal suppression (long-term use)
- hypercorticism (long-term use)
- immunosuppression (long-term use)
- glaucoma (long-term use)
- cataracts (long-term use)
- osteoporosis (long-term use)
- growth suppression (long-term use in peds pts)
Common Reactions
- URI
- headache
- pharyngitis
- cough
- sinusitis
- nausea
- vomiting
- dyspepsia
- bronchitis
- pneumonia (COPD use)
- hoarseness
- dysphonia
- throat irritation
- dizziness
- palpitations
- tremor
- taste changes
- diarrhea
- dermatitis
- candidiasis, oral
- candidiasis, esophageal
- central serous chorioretinopathy
Safety/Monitoring .
Monitoring Parameters
BMD at baseline if osteoporosis risk factors or COPD, then periodically; height in children/adolescents; oral cavity exam periodically; consider ophthalmic exam if long-term use, change in vision, IOP/glaucoma/cataracts hx
Pregnancy/Lactation .
Pregnancy
Clinical Summary
fluticasone propionate: may use during pregnancy; risk of teratogenicity low based on human data
salmeterol inhaled: weigh risk/benefit during pregnancy, esp. during labor and delivery; risk of fetal harm low based on limited human data; risk of interference w/ uterine contractility based on drug's mechanism of action
Lactation
Clinical Summary
fluticasone propionate: may use while breastfeeding; no human data available, though risk of infant harm not expected based on minimal systemic absorption in breastfeeding pts and drug properties; no human data available to assess effects on milk production
salmeterol inhaled: may use while breastfeeding; no human data available, though risk of infant harm not expected based on minimal systemic absorption in breastfeeding pts; no human data available to assess effects on milk production
Pharmacology .
Metabolism: for fluticasone propionate: liver primarily; CYP450: 3A4 substrate; Info: minimal systemic absorption; for salmeterol: liver extensively; CYP450: 3A4 substrate; Info: minimal systemic absorption
Excretion: for fluticasone propionate: feces primarily; Half-life: 7.8h; for salmeterol: feces primarily; Half-life: 5.5h
Subclass: Beta-2 Agonists, Inhaled Long-Acting (LABAs) ; Corticosteroids, Inhaled
Mechanism of Action
fluticasone propionate's exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects; salmeterol selectively stimulates beta-2 adrenergic receptors, relaxing airway smooth muscle
Formulary .
No Formulary Selected
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.